Coca-cola Icecek A.s. · BIST:CCOLA
Coca-cola Icecek A.s — 9M2007 Earnings Presentation
15 slides from Coca-cola Icecek A.s's earnings presentation, Nov 21, 2007
Slide 1: Results for the nine month period ending September 30, 2007
Results for the nine month period ending September 30, 2007 November 21st, 2007 İstanbul, Turkey 1
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation includes forward-looking statements including, but not limited to, statements regarding Coca-Cola İçecek’s (“CCI”) plans, objectives, expectations and intentions and other statements that are not historical facts. Forward-looking statements can generally
Slide 3: Healthy Growth in 9M2007
Healthy Growth in 9M2007 Turkey Volume International Volume Consolidated Volume (Unit cases in millions) (Unit cases in millions) (Unit cases in millions) 320 400 11% 80 23% 13% 300 70 360 280 311 60 389 79 343 279 64 320 260 50 240 40 280 9M06 9M07 9M06 9M07 9M06 9M07 3Q07 3
Slide 4: Strong Growth in 9M2007 - Net Sales
Strong Growth in 9M2007 Turkey Net Sales International Net Sales Consolidated Net Sales (CMB - YTL in millions) (CMB – US$ in millions) (CMB - YTL in millions) 1,300 15% 210 24% 15% 1,600 190 1,200 170 1,400 1,100 150 1,200 130 1,000 1,297 201 1,565 110 1,133 162 1,000 900 90 1,363 800 70 800 50 600
Slide 5: Strong Growth in 9M2007 - EBITDA
Strong Growth in 9M2007 Turkey EBITDA International EBITDA Consolidated EBITDA (CMB - YTL in millions) (CMB – US$ in millions) (CMB - YTL in millions) 40 270 29% 250 36 27% 37 300 28% 267 318 230 32 260 210 28 190 207 20.6% 29 18.5% 220 248 20.3% 24 170 18.2% 18.1% 18.2% 150 180 20 9M06 9M07 9M06 9M
Slide 6: Turkey
Turkey Demand for FMCG accelerated further in Q3 Strong CSD volume growth in Q3 was driven by nationwide promotions including an excellent Ramadan promotion Two new Cappy flavors introduced plus 250ml OWB and 330ml PET bottle launched in June Net sales revenue increase above volume due to the favora
Slide 7: International Operations – Central Asia
International Operations – Central Asia Kazakhstan: New pet and tetra pack lines operational Cappy launched with 5 flavors in October 2007 in premium segment Azerbaijan: Additional filling and preform capacity added in July Focus on market presence and branding execution intensified Kyrgyzstan: New
Slide 8: International Operations – Middle East
International Operations – Middle East Jordan: Fine tuning of Business Model continues Riwa, water brand, performing well Improved route-to-market systems in place Iraq: Construction of new plant continues Building Coca-Cola brand awareness and presence Developing a direct sales and delivery system
Slide 9: Financial Review
Financial Review Burak Başarır CFO 9
Slide 10: Introduction to Financial Statements
Introduction to Financial Statements Basis of Preparation Consolidated / Turkey International YTL/$ Exchange Rates Functional Currency YTL USD September 30, 2007 1.2048 Reporting Currency YTL USD December 31, 2006 1.4056 Net Sales – Net of discounts and special consumption tax for Turkish operations
Slide 11: Key Financials
Key Financials Financial Period Ending September 30th 2007 2006 ’07 vs. ‘06 (YTL in millions unless otherwise stated) Sales Volume (UC m) 389.0 342.9 13.4% Net Revenue 1,564.5 1,363.2 14.8% Gross Profit 648.7 445.8 45.5% Gross Profit Margin 41.5% 32.7% EBITDA 317.6 248.3 27.9% EBITDA Margin 20.3% 18
Slide 12: Balance Sheet
Balance Sheet Financial Period Ending Financial Year Ending Financial Period Ending Financial Year Ending Assets September 30, 2007 December 31,2006 Liabilities andEquity September 30, 2007 December 31, 2006 177.3 50.9 263.8 214.1 (YTL in millions unless otherwise stated) Cash & cash equivalents Sho
Slide 13: Guidance
Guidance Volume Growth Guidance Turkey: high single – low double digit International : high teens – low twenties Management’s Focus Revenue growth in excess of volume growth EBITDA growth in excess of revenue growth Tax VAT on CSDs down from 18% to 8% as of January 1, 2008 13
Slide 14: Closing Remarks
Closing Remarks 14
Slide 15: Q&A Session
Q&A Session 15